Background {#Sec1}
==========

Magnetic resonance imaging (MRI) is commonly used to study knee osteoarthritis (OA), largely because of its ability to visually detect morphological changes in soft tissues \[[@CR1]--[@CR6]\]. However, in addition to visualizing structures within a joint, the measurable characteristics of MRI enable the quantification of tissue biochemistry, often termed compositional MRI.

Although several types of compositional MRI techniques exist, the vast majority of research in OA focuses on knee articular cartilage T2 and T1ρ relaxation times as these are suggested to show considerable promise and be clinically feasible \[[@CR7]--[@CR10]\]. Although the reported strengths of the correlations are variable, T2 and T1ρ relaxation times are associated with the composition of the extracellular matrix. T2 relaxation is inversely correlated with collagen network organization and structure, and is directly correlated with free water content \[[@CR7]\]. Changes in T1ρ relaxation appear to be less specific, yet are also sensitive to changes in the extracellular matrix \[[@CR8]--[@CR14]\]. When the extracellular matrix of articular cartilage is compromised, characteristic of early biochemical processes in OA, water moves more freely within the cartilage, prolonging both MRI T2 and T1ρ relaxation time \[[@CR13], [@CR15], [@CR16]\].

T2 and T1ρ relaxation have engendered considerable interest as a potential biomarkers for knee OA \[[@CR17]\], especially given their proposed ability to detect biochemical changes in articular cartilage before structural changes are evident \[[@CR15], [@CR18], [@CR19]\]. If these measures can detect compromised articular cartilage prior to radiographic evidence of OA, they may have the potential to serve as an outcome measure in early intervention studies targeting at-risk populations, such as people with knee anterior cruciate ligament (ACL) rupture \[[@CR20]--[@CR22]\], meniscal injuries \[[@CR23], [@CR24]\], or obesity \[[@CR25], [@CR26]\]. While this may be true of other compositional MRI measures (such as sodium, glycosaminoglycan chemical exchange saturation transfer \[gagCEST\], delayed gadolinium enhanced MRI of cartilage \[dGEMRIC\] \[[@CR27]\]), T2 and T1ρ relaxation are perhaps the most clinically feasible, do not require a contrast agent, and are the focus of numerous studies that may enable meta-analysis when investigating their potential use as a biomarker.

Previous systematic reviews are encouraging in that they suggest T2 and T1ρ measures can be highly reliable when similar testing methods are used \[[@CR27]\], and can distinguish between articular cartilage of healthy controls and patients with established radiographic OA \[[@CR27], [@CR28]\]. There are established criteria, however, for biomarker validation and qualification \[[@CR29]--[@CR31]\]. These include the ability to consistently measure the biomarker across testing sites \[[@CR32], [@CR33]\]. The extent to which previous studies investigating compositional MRI have used similar collection and analysis methods is presently unclear, and has been recently called into question \[[@CR34]\]. Moreover, the potential utility of a biomarker to detect changes in the composition of knee articular cartilage relies on its ability to do so early in the disease process, before degenerative joint changes are evident on x-ray. Although there is abundant evidence suggesting T2 and T1ρ relaxation times are prolonged in knees with established radiographic OA compared to healthy knees \[[@CR27], [@CR28]\], the ability to detect changes between knees at risk for OA and healthy knees is less clear.

Therefore, purposes of this systematic review and meta-analysis were to: 1) summarize the MRI methods of published studies investigating T2 and T1ρ relaxation times in participants at risk for but without radiographic knee OA; and 2) compare T2 and T1ρ relaxation values between participants at-risk for knee OA and healthy controls.

Methods {#Sec2}
=======

This systematic review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines \[[@CR35]\] (Additional file [1](#MOESM1){ref-type="media"}: Appendix 5) (PROSPERO ID: CRD42018088352).

Literature search {#Sec3}
-----------------

We sought the assistance of a research librarian to develop the search strategy. We searched the following electronic databases from their inception to June 2018: MEDLINE, EMBASE, Scopus, Cumulative Index to Nursing & Allied Health Literature (CINAHL), SPORTDiscus, and Web of Science, in addition to hand searching reference lists of included articles. Combined and truncated keywords and subject headings included "*magnetic resonance imaging* OR *compositional magnetic resonance imaging*" AND "*T2 mapping* OR *T1rho mapping* OR *T2 relaxation* OR *T1rho relaxation*" AND "*osteoarthritis* OR *articular cartilage*" AND "*knee* OR *tibiofemoral* OR *patellofemoral*". A full example of the search strategy is provided in Additional file [1](#MOESM1){ref-type="media"}: Appendix 1.

Eligibility criteria {#Sec4}
--------------------

Eligible studies included those published in English that reported T2 and/or T1ρ relaxation time in knee articular cartilage in at least two groups of participants including one group with any of the criteria commonly accepted for being at risk for knee OA, and a control group without any of those criteria. All study designs were considered. We used the Osteoarthritis Initiative (OAI) Incidence cohort criteria \[[@CR36]\] to define a list of criteria for participants at risk for knee OA. These criteria include native knee symptoms in the past 12 months, overweight or obesity, history of knee injury which would cause difficulty walking for at least a week, history of knee surgery, family history of OA, lifestyle factors such as occupational risk (i.e. repetitive knee bending, squatting, lifting, etc.), age 70 years or older, and Kellgren & Lawrence (KL) radiographic grading of 0 or 1 \[[@CR37]\]. Studies that included at-risk knees and contralateral healthy knees within the same participant were also included. We excluded patients with KL grade 2 or higher. For studies with multiple follow-up time points, only the baseline T2 and/or T1ρ relaxation data were used in our meta-analyses. Two reviewers independently assessed the eligibility of each article in two stages. Two reviewers independently assessed all titles and abstracts identified by the search. Articles meeting the inclusion criteria, according to at least one reviewer, were obtained as full-text manuscripts for further review. Articles meeting the inclusion criteria after full-text review were accepted in the review. Reviewers discussed any conflicts at all stages and a consensus was achieved.

Data extraction {#Sec5}
---------------

Two reviewers independently extracted T2 and T1ρ relaxation time of knee articular cartilage in six primary compartments: medial femoral condyle (MF), medial tibial plateau (MT), lateral femoral condyle (LF), lateral tibial plateau (LT), patellar cartilage (P), and trochlear groove of the femur (TrF) cartilage. If authors presented laminar differences (superficial and deep cartilage as separate regions of interest) the data from both regions were pooled. Given the variability in defining anterior, central, and posterior subregions of the femur and tibia across studies, we pooled the identified subregions (where necessary) to best analyze the load-bearing regions of the femoral condyles (generally in the region of the anterior horn of the meniscus to the posterior horn of the meniscus). For the P and TrF, we pooled all subregions (where necessary) to obtain a single value for the P or TrF. Reviewers discussed any conflicts and achieved consensus in all cases. Reviewers independently extracted relaxation time means and standard deviations (SD) for each participant group. The same reviewers also extracted the following information from each article: sample size, participant demographics, risk factors for OA, MRI hardware, pulse sequences, and parameters. Authors were contacted when sufficient data were not reported. If data were not provided or unclear, we contacted the original authors using provided e-mail addresses. In the case of no reply from the authors, we extracted data from figures when available. We used Covidence systematic review and meta-analysis software ([www.covidence.org](http://www.covidence.org)) to extract data.

Quality assessment {#Sec6}
------------------

Two reviewers independently evaluated the methodological quality of each study using the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) tool \[[@CR38]\], consisting of seven items to assess the internal validity of each study (confounding, participant selection, intervention classification, deviation from intervention, missing data, outcome measurement, and outcome selection). Each item was evaluated as a low, moderate, serious, or critical risk of bias. Disagreements between reviewers were resolved by consensus after initial independent evaluation.

Data analyses {#Sec7}
-------------

We assessed agreement between reviewers using the kappa (κ) statistic. We compared compositional MRI data by calculating pooled estimates with 95% confidence intervals (95% CIs) for standardized mean differences (SMDs) using random-effects models. When calculating pooled effect sizes, we weighted all SMDs based on the sample size of the respective study. For both T2 and T1ρ relaxation time, the SMD was calculated using the difference between healthy controls and participants at risk for knee OA, divided by the pooled SD. If a study had multiple groups at risk for knee OA, only the group with the lowest risk was included in the calculation of the overall pooled effect size, based on reported measures of disease severity (KL Grade, International Cartilage Repair Society \[ICRS\] grade, Outerbridge Score, Whole Organ MRI Score \[WORMS\], etc.). All meta-analyses were performed using the Comprehensive Meta-Analysis software program (V3, Biostat; <https://www.meta-analysis.com>). We interpreted the magnitude of the SMD using Cohen's *d* as small (\< 0.2), moderate (0.2--0.8) and large (\> 0.8) and positive values representing prolonged relaxation times in participants at risk for OA \[[@CR39]\]. We assessed publication bias using the Egger's Regression test \[[@CR40]\], and if present, further analyses were planned to explore treatment effects adjusted for selective reporting \[[@CR41]\]. We assessed the proportion of variability associated with heterogeneity using the I^2^ statistic and Q statistic \[[@CR42]\]. We interpreted the size of I^2^ as low (25%), moderate (50%) or high (75%) heterogeneity \[[@CR42]\].

Sensitivity analyses {#Sec8}
--------------------

We repeated the primary analyses after excluding all but one study (with the greatest sample size) that included OAI participants to ensure we included data from the same knee only once. We also repeated the analyses after excluding studies that used both limbs from the same participant.

In the event of substantial heterogeneity, we planned three subgroup analyses. These groups included participants with a history of ACL injury (based on physical exam, imaging, or surgical confirmation), participants at risk for patellofemoral OA (based on the OAI Incidence cohort criteria) \[[@CR36]\], and participants with articular cartilage injuries based on MR imaging, arthroscopic ICRS grades, or Outerbridge scores \[[@CR43], [@CR44]\].

Results {#Sec9}
=======

Study selection & article screening {#Sec10}
-----------------------------------

We performed the initial search August 1st, 2018 and updated the search March 7th, 2019. We identified 6417 articles by the database search. After removing duplicates, we reviewed 3071 articles by title and abstract with excellent inter-rater agreement (κ =0.96) and 53 disagreements (1.7%) between reviewers. Disagreements were discussed, and after consensus, 386 articles were deemed eligible for full-text review (Fig. [1](#Fig1){ref-type="fig"}). After full text reviews, inter-rater agreement was excellent (κ =0.95), with 12 disagreements between reviewers. Disagreements were discussed, and after consensus, 55 articles met our inclusion criteria (Fig. [1](#Fig1){ref-type="fig"}) \[[@CR15], [@CR16], [@CR20], [@CR23], [@CR24], [@CR45]--[@CR94]\], with a total of 3676 participants. Forty-seven studies were included in the meta-analysis, including data from 3079 participants. Articles included in the systematic review but excluded from the meta-analysis either examined incomparable regions of interest (ROI), or had insufficient data to be included in the meta-analyses \[[@CR54], [@CR66], [@CR68], [@CR69], [@CR77], [@CR85], [@CR89], [@CR90]\].Fig. 1PRISMA flowchart quantifying studies accepted and rejected with reasons at different phases of review

Study characteristics {#Sec11}
---------------------

Characteristics of all studies included in the systematic review are described in Table [1](#Tab1){ref-type="table"} \[[@CR15], [@CR16], [@CR20], [@CR23], [@CR24], [@CR45]--[@CR94]\]. T2 relaxation was included as an outcome measure in 38 studies, T1ρ relaxation was an outcome measure in 24 studies, and 8 of those studies evaluated both T2 and T1ρ relaxation. Studies varied considerably in terms of compositional MRI data acquisition and post-processing. Two different magnet strengths, four different manufacturers, 12 different magnet models, 16 different reported knee coils, 17 reported pulse sequences, and a wide variety of parameters were used to acquire compositional MRI data.Table 1Description of studies included in the systematic reviewAuthorsParticipantsn (n~male~)AgeScannerCoilT1ρ Sequence (resolution)TSL (ms)/SL Frequency (Hz)T2 Sequence (resolution)TR/TEAmano et al. (2016)^c^Control19 (13)31±53T GEInvivo 8-Ch Tx/RxSag 3D MAPSS (0.3×0.3×1.5)0, 10, 40, 80/500Sag 3D MAPSS (0.3×0.3×1.5)4000/0, 13, 26, 51ACL injured51 (29)29±9van der Heijden et al. (2016)^c^Control70 (29)23±63T GEInvivo 8-Ch Tx/Rx3D FSE (0.5×0.8×3.0) \[3 slices/SR\]1, 16, 32, 64, 125/5003D FSE (0.5×0.8×3.0) \[3 slices/SR\]1263/3, 13, 27, 40, 68PFP64 (35)23±7Apprich et al. (2010)^bc^ICRS Grade 014 (N/A)37±83T Siemens8-Ch Knee Array\-\-\--Ax 2D MESE (0.4×0.4×3.0)1200/14, 28, 41, 55, 69, 83ICRS Grade 15 (N/A)37±8Apprich et al. (2012)^bc^ICRS Grade 011 (N/A)30±93T Siemens8-Ch Knee Array\-\-\--Ax 2D MESE (0.2×0.2×2.0)1200/14, 28, 41, 55, 69, 83ICRS Grade 110 (N/A)30±9Bae et al. (2015)^bc^Uninjured Knee10 (7)34±83T SiemensSiemens 8-Ch Tx/Rx\-\-\--2D ME-FSE (0.5×0.5×3.0) \[3 slices/SR\]1700/11, 21, 32, 42, 53, 64, 74, 85, 95, 106ACLR Knee10 (7)34±8Baum et al. (2012)^ac^OAI Healthy42 (21)50±33T SiemensSiemens 15-Ch Tx/Rx\-\-\--Sag 2D MESE (0.3×0.4×3.0)2700/10, 20, 30, 40, 50, 60, 70OAI Incidence42 (21)50±3Baum et al. (2013)^ac^OAI Healthy36 (11)50±33T SiemensSiemens 15-Ch Tx/Rx\-\-\--Sag 2D MESE (0.3×0.4×3.0)2700/10, 20, 30, 40, 50, 60, 70OAI Incidence78 (33)51±3Baum et al. (2012)^ac^OAI Healthy41 (15)51±33T SiemensSiemens 15-Ch Tx/Rx\-\-\--Sag 2D MESE (0.3×0.4×3.0)2700/10, 20, 30, 40, 50, 60, 70OAI Incidence101 (50)51±3Möstrom et al. (2015)^c^Healthy Control16 (9)22±21.5T PhilipsN/R\-\-\--Sag 2D MESE (0.5×0.5×3.0)2000/9, 18, 27, 36, 45, 54, 63, 72Patellar Dislocation16 (9)22±2Bining et al. (2009)^c^Healthy Control60 (N/A)38±141.5T GESigna HD Tx/Rx\-\-\--Sag 2D MESE (0.6×0.6×4.0)1000/8, 16, 24, 32, 40, 48, 56, 64Cartilage Lesions24 (N/A)45±17Bolbos et al. (2008)^c^Healthy Control15 (11)30±93T GETx/Rx Quadrature KneeSag 3D SPGR (0.5×0.7×3.0)0, 10, 40, 80/500\-\-\--ACL Rupture16 (11)33±6Farrokhi et al. (2011)^bc^Healthy Control10 (0)27±43T GEGE 8-Ch Knee\-\-\--Sag 2D MESE (0.4×0.8×4.0) \[3 slices/SR\]1800/20, 40, 60, 80PFP10 (0)28±4Gheno et al. (2016)^c^Healthy Control27 (22)28±43T PhilipsInvivo 8-Ch Tx/Rx\-\-\--Sag 2D MESE (0.3×0.3×3.0)3100/15, 30, 45, 60, 75, 90ACLR27 (22)29±5Van Ginckel et al. (2013)Healthy Control15 (8)27±33T Siemens8-Ch Knee\-\-\--Sag 2D MESE (0.4×0.4×3.0)1000/14 28, 41, 55, 69ACLR15 (8)27±1Gupta et al. (2014)^c^Healthy Control10 (8)35±63T GETx/Rx Quadrature KneeSag 3D SPGR (0.5×1.1×4.0) \[3 slices/SR\]0, 10, 40, 80/500\-\-\--ACL Injury10 (5)39±6Haughom et al. (2012)^c^Healthy Control11 (4)33±93T GE8-Ch Tx/RxSag 3D SPGR (0.3×0.6×1.5)0, 10, 40, 80/500\-\-\--ACLR11 (4)33±9Hovis et al. (2011)^ac^OAI Healthy33 (8)50±33T SiemensN/R\-\-\--Sag 2D MESE (0.3×0.4×3.0)2700/10, 20, 30, 40, 50, 60, 70OAI Incidence128 (57)51±3Joseph et al. (2011)^ac^OAI Healthy53 (17)50±33T SiemensN/R\-\-\--Sag 2D MESE (0.3×0.4×3.0)2700/10, 20, 30, 40, 50, 60, 70OAI Incidence93 (42)51±3Kai et al. (2011) ^c^Healthy Control143 (72)40±131.5T SiemensSigna HD 8-Ch Tx/Rx\-\-\--Sag 2D MESE (0.6×0.6×4.0)1000/8, 16, 24, 32, 40, 48, 56, 64Meniscal Lesions57 (27)41±13Kang et al. (2016)^c^Healthy Control53 (15)16±21.5T GEN/R\-\-\--Sag 2D MESE (0.5×0.9×4.0)1500/9, 18, 27, 36, 45, 54, 63, 72, 81, 90, 99PF Instability53 (15)16±2Lansdown et al. (2015)^bc^Healthy Control10 (4)31±53T GEInvivo 8-Ch Tx/RxSag 3D MAPSS (0.6×0.6×3.0)0, 10, 40, 80/500\-\-\--ACLR20 (8)32±8Lau et al. (2016)^c^Healthy Control6 (3)293T GEInvivo 8-Ch Tx/Rx2D FSE (0.3×0.6×1.5)0, 10, 40, 80/500\-\-\--PFP10 (2)32Liebl et al. (2015)^a^OAI Healthy80 (30)58±83T SiemensUSA Instruments Tx/Rx\-\-\--Sag 2D MESE (0.3×0.4×3.0)2700/10, 20, 30, 40, 50, 60, 70OAI Incidence50 (22)60±8H. Li et al. (2013)^c^Healthy Control15 (15)27±53T SiemensN/R\-\-\--Sag 2D MESE (0.4×0.4×3.0) \[5 slices/SR\]1523/14, 28, 41, 55, 69ACLR30 (30)29±5X. Li et al. (2011)^ac^Healthy Control10 (7)343T GEQuadrature Tx/RxSag 3D SPGR (0.5×1.1×2.5)20, 40. 60, 80/500Sag 2D MESE (0.5×1.1×2.5)2000/7, 12, 28, 60ACL Injured12 (7)34Matsubara et al. (2015)^c^Healthy Control19 (19)39±73T Philips8-Ch Tx/RxSag 2D FFE (0.4×0.4×3.0) \[3 slices/SR\]1, 20, 40, 60, 80/500\-\-\--Meniscal Tear22 (15)57±14Mosher et al. (2004)18-30 y.o. Healthy8 (0)25±13T BrukerDoty Scientific Litz\-\-\--Sag 2D MESE (0.5×0.5×3.0)1500/9, 18, 27, 36, 45, 54, 63, 72, 81, 90, 99, 10866-86 y.o. Healthy7 (0)75±7Okazaki et al. (2015)^c^Healthy Control6 (N/A)32±23T Philips8-Ch Tx/RxSag 2D SPGR (0.4×0.4×3.0) \[4 slices/SR\]1, 20, 40, 60, 80/500\-\-\--PCL Deficient6 (N/A)17±6Osaki et al. (2015)^c^Healthy Control14 (14)37±63T Philips8-Ch Tx/RxSag 2D SPGR (0.4×0.4×3.0) \[3 slices/SR\]1, 20, 40, 60, 80/500\-\-\--ACL Injured49 (30)25±9Palmieri-Smith et al. (2016)Healthy Control11 (5)20±53T PhilipsN/R\-\-\--Sag 2D MESE (0.5×0.5×2.0)1000/8, 16, 24, 32, 40, 48, 56, 64ACL Injured11 (5)19±6Pedoia et al. (2015)^c^Healthy Control15 (N/A)32±53T GEInvivo 8-Ch Tx/RxSag 3D MAPSS (0.5×1.1×4.0)0, 10, 40, 80/500\-\-\--ACL Injured40 (N/A)30±8Pedoia et al. (2016)^c^Healthy Control10 (5)32±43T GEInvivo 8-Ch Tx/RxSag 3D MAPSS (0.5×1.1×4.0)0, 10, 40, 80/500\-\-\--ACL Injured52 (21)28±12Pedoia et al. (2017)^c^Healthy Control15 (10)31±53T GEInvivo 8-Ch Tx/RxSag 3D MAPSS (0.5×1.1×4.0)0, 10, 40, 80/500Sag 3D MAPSS (0.5×1.1×4.0)4000/0, 14, 27, 55ACL Injured40 (25)30±8Rehnitz et al. (2014)^c^Healthy Control10 (N/A)253T SiemensSiemens 15-Ch Tx/Rx\-\-\--Sag 2D MESE (0.4×0.4×3.0) \[3 slices/SR\]1940/12, 24, 35, 47, 59, 71, 83, 94, 106, 118, 130, 142, 153Cartilage Lesions40 (N/A)47Russell et al. (2017)^c^Healthy Control15 (6)57±93T GEInvivo 8-Ch Tx/RxSag 2D SPGR (0.5×1.1×4.0)0, 2, 4, 6, 8, 12, 20, 40, 80/500Sag 2D MESE (0.5×1.1×4.0)4000/0, 2, 4, 7, 15, 29, 44, 58Cartilage Lesions15 (6)56±8Sauerschnig et al. (2014)^c^Neutral12 (4)25±21.5T SiemensMedical Advances 8-Ch\-\-\--Sag 2D MESE (0.4×0.5×1.0)1690/10, 20, 30, 40, 50, 60Varus Alignment12 (10)26±1ACLR40 (26)35±8Snoj et al. (2016)^bc^Healthy Controls20 (11)33±73T SiemensInvivo 8-Ch Tx/Rx\-\-\--Sag 2D MESE (0.4×0.4×3.0) \[2 slices/SR\]1000/14, 28, 41, 55, 69, 83ACLR40 (26)35±8Subhawong et al. (2014)^c^Healthy Control28 (17)31±103T SiemensN/R\-\-\--Sag 2D MESE (N/A) \[1 slice/SR\]1650/13, 26, 39, 52, 65, 77PFP22 (8)34±13Su et al. (2013)^c^Healthy Control16 (8)333T GEClinical MR Solutions Tx/Rx QuadratureCor 3D SPGR (0.5×0.7×4.0)0, 10, 40, 80/500Sag 3D SPGR (0.5×0.7×4.0)2000/4, 15, 25, 46ACL Injured15 (7)35Su et al. (2016)^c^Healthy Control54 (31)30±83T GEClinical MR Solutions Tx/Rx QuadratureCor 3D SPGR (0.5×0.7×4.0)0, 10, 40, 80/500Sag 3D SPGR (0.5×0.7×4.0)2000/4, 15, 25, 46ACL Injured54 31(31)30±8Theologis et al. (2014)^bc^Healthy Control18 (8)38±83T GEClinical MR Solutions Tx/Rx QuadratureSag 3D SPGR (0.5×0.7×4.0)0, 10, 40, 80/500\-\-\--ACLR18 (8)38±8Thuiller et al. (2013)^c^Healthy Control10 (4)31±33T GEInvivo 8-Ch Tx/Rx2D FSE (0.3×0.6×1.5)0, 10, 40, 80/500\-\-\--PFP20 (10)31±5Wirth et al. (2016)^ac^Healthy Control89 (36)55±83T SiemensSiemens 15-Ch Tx/Rx\-\-\--Sag 2D MESE (0.3×0.3×3.0)2700/10, 20, 30, 40, 50, 60, 70Risk for OA28 (14)61±9Witschey et al. (2010)Healthy Controls9 (2)N/R1.5T SiemensInvivo 8-Ch Tx/Rx3D GRE (0.5×0.6×0.5)\-\-\-\-\--Cartilage Lesions6 (3)N/RXu et al. (2011)Healthy Controls30 (18)253T PhilipsSENSE 8-Ch\-\-\--Sag 2D MESE (0.5×0.3×3.0)2400/15, 30, 45, 60, 75, 90Cartilage Injury42 (25)37Zaid et al. (2015)^bc^Healthy Controls25 (12)28±73T GEInvivo 8-Ch Tx/RxSag 3D SPGR (0.5×1.1×4.0)\-\-\-\-\--ACLR25 (12)28±7Kim et al. (2018)^bc^Healthy Control10 (7)34±83T SiemensSiemens 8-Ch\-\-\--Sag 2D MESE (0.5×0.5×3.0) \[2 slices/SR\]1700/11, 21, 32, 42, 53, 64, 72, 85, 95, 106ACLR10 (7)34±8Kogan et al. (2018)^c^Healthy Control15 (10)33±113T GENeoCoil 16-Ch Tx/Rx Flex\-\-\--3D DESS (0.5×0.5×1.5)24.6/5.8, 43.4ACL Injured15 (10)33±11Mostrom et al. (2017)^c^Healthy Control17 (5)25±31.5T PhilipsN/R\-\-\--Sag 2D MESE (0.5×0.5×3.0)2000/9, 18, 27, 36, 45, 54, 63, 72PF Instability17 (5)25±3Pfeiffer et al. (2017)^abc^Healthy Control21 (11)24±33T SiemensSiemens XR 80/200 Gradient Coil3D FLASH (1.8×0.9×3.0)0, 10, 20, 30, 40/500\-\-\--ACLR21 (11)24±3Pietrosimone et al. (2017)^bc^Healthy Control18 (8)22±43T SiemensSiemens 4-Ch Flex Coil3D FLASH (0.6×1.3×3.0)0, 10, 20, 30, 40/500\-\-\--ACLR18 (8)22±4Tao et al. (2018)^c^Healthy Control23 (7)29±83T SiemensSiemens 8-Ch Tx/Rx\-\-\--Sag 2D MESE (0.4×0.4×3.0)1523/13.8, 27.6, 41.4, 55.2, 69.0ACL Rupture23 (5)32±10Teng et al. (2017)^c^Healthy Control12 (8)32±63T GEInvivo 8-Ch Tx/RxSag 3D MAPSS (0.5×1.1×4.0)0, 10, 40, 80/500Sag 3D MAPSS (0.5×1.1×4.0)0, 14, 27, 55ACL Rupture33 (20)31±9Wang et al. (2018)^c^Healthy Control9 (4)26±53T SiemensSiemens 8-Ch\-\-\--Sag 2D MESE (0.4×0.4×3.0) \[3/5/10 slices/SR\]1200/14, 28, 41, 55, 69ACLR28 (17)30±6Collins et al. (2018)^b^Normal BMI8 (5)303T SiemensInvivo 8-Ch Tx/RxSag 3D FISP (1.1×0.5×3.0)3500/5, 10, 40, 80/500\-\-\--Obese BMI7 (3)32*ms* milliseconds, *SL* spin lock, *Hz* Hertz, *TR* Repetition time, *TE* echo time, *ACL* anterior cruciate ligament, *ACLR* ACL reconstruction, *GE* General Electric, *MAPSS* magnetization-prepared spoiled gradient echo, *SR* subregion, *PF* patellofemoral, *PFP* patellofemoral pain, *FFE* fast field echo, *FSE* fast spin echo, *ICRS* International Cartilage Rating Scale, *Ch* channel, *Sag* sagittal, *Cor* coronal, *Ax* axial, *MESE* multi-echo spin echo, *OAI* Osteoarthritis Initiative, *Tx* transmit, *Rx* receive, *N/R* not reported, *SPGR* spoiled gradient recalled echo, *FISP* fast imaging with steady state precession^a^multicenter study^b^use of pre-scan unloading protocol^c^indicates post-processing methods that could be used in any dataset

Quality assessment {#Sec12}
------------------

Agreement between reviewers for all seven items in the ROBINS-I tool was moderate (κ =0.54, 95% CI = 0.48--0.61), with disagreements being primarily on the subjective severity of bias rather than the presence or absence of bias. Forty-five studies presented with a moderate overall risk of bias, seven presented with a serious risk of bias, and three presented with a low risk of bias. The most common sources of risk for bias was lack of blinding, or reporting of blinding, of the outcome assessors, as well as risk of bias in participant selection. No studies were excluded based on quality assessment. Results of the quality assessment are included in Additional file [1](#MOESM1){ref-type="media"}: Appendix 2.

Descriptive analyses {#Sec13}
--------------------

Forty-seven out of 55 studies observed a significant increase in compositional MRI values in one or more regions of interest in the at-risk group compared to the healthy control group. Specifically, 31 of 38 studies assessing T2 relaxation time reported significant lengthening in the at-risk group, and 21 of 24 studies assessing T1ρ relaxation time reported significant lengthening in the at-risk group.

Meta-analyses {#Sec14}
-------------

We were able to pool data for T2 and/or T1ρ relaxation time for cartilage ROIs in the MF and LF, MT and LT, P, and TrF cartilage. Forest plots, including individual and pooled SMDs are presented in Figs. [2](#Fig2){ref-type="fig"}, [3,](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}.Fig. 2**a** Forest plots illustrating individual and pooled SMD for differences in T1rho and T2 relaxation time of medial femoral articular cartilage between healthy controls and participants at risk for knee OA. SMD = standardized mean difference, 95% CI = 95% confidence interval, ACL = anterior cruciate ligament, PCL = posterior cruciate ligament, ICRS=International Cartilage Repair Society, OAI=Osteoarthritis Initiative, OA = osteoarthritis, GE = General Electric, T = Tesla. **b** Forest plots illustrating individual and pooled SMD for differences in T1rho and T2 relaxation time of medial tibial articular cartilage between healthy controls and participants at risk for knee OA. SMD = standardized mean difference, 95% CI = 95% confidence interval, ACL = anterior cruciate ligament, PCL = posterior cruciate ligament, ICRS=International Cartilage Repair Society, OAI=Osteoarthritis Initiative, OA = osteoarthritis, GE = General Electric, T = TeslaFig. 3**a** Forest plots illustrating individual and pooled SMD for differences in T1rho and T2 relaxation time of lateral femoral articular cartilage between healthy controls and participants at risk for knee OA. SMD = standardized mean difference, 95% CI = 95% confidence interval, ACL = anterior cruciate ligament, PCL = posterior cruciate ligament, ICRS=International Cartilage Repair Society, OAI=Osteoarthritis Initiative, OA = osteoarthritis, GE = General Electric, T = Tesla. **b** Forest plots illustrating individual and pooled SMD for differences in T1rho and T2 relaxation time of lateral tibial articular cartilage between healthy controls and participants at risk for knee OA. SMD = standardized mean difference, 95% CI = 95% confidence interval, ACL = anterior cruciate ligament, PCL = posterior cruciate ligament, ICRS=International Cartilage Repair Society, OAI=Osteoarthritis Initiative, OA = osteoarthritis, GE = General Electric, T = TeslaFig. 4**a** Forest plots illustrating individual and pooled SMD for differences in T1rho and T2 relaxation time of patellar articular cartilage between healthy controls and participants at risk for knee OA. SMD = standardized mean difference, 95% CI = 95% confidence interval, ACL = anterior cruciate ligament, ICRS=International Cartilage Repair Society, OAI=Osteoarthritis Initiative, OA = osteoarthritis, GE = General Electric, T = Tesla. **b** Forest plots illustrating individual and pooled SMD for differences in T1rho and T2 relaxation time of trochlear articular cartilage between healthy controls and participants at risk for knee OA. SMD = standardized mean difference, 95% CI = 95% confidence interval, ACL = anterior cruciate ligament, ICRS=International Cartilage Repair Society, OAI=Osteoarthritis Initiative, OA = osteoarthritis, GE = General Electric, T = Tesla

At-risk knees had significantly prolonged T2 relaxation times for all compartments, small-to-moderate effect sizes (SMD = 0.33--0.74; *p* \< 0.001; Figs. [2](#Fig2){ref-type="fig"}, [3,](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}). At-risk knees had significantly prolonged T1ρ relaxation times for the MF and LF with small effect sizes (SMD = 0.35--0.40; *p* \< 0.001; Figs. [2a](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"}a). There were no significant differences in T1ρ relaxation between groups for the MT, LT, P, or TrF compartments (SMD = 0.04--0.19, *p* \> 0.05--0.76; Figs. [2b](#Fig2){ref-type="fig"}, [3b](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}b).

Publication Bias and heterogeneity {#Sec15}
----------------------------------

Egger's regression test for publication bias was not significant for any meta-analysis assessing pooled SMD of T2 relaxation time. For T1ρ relaxation time, meta-analyses of the MF and LT compartments showed significant evidence of publication bias (*p* \< 0.01). After using Duval & Tweedie's trim and fill method \[[@CR41]\] to correct for publication bias, T1ρ relaxation time of the MF was not significantly different in participants at risk for knee OA (SMD = 0.16\[95% CI:-0.07;0.40\]; *p* = 0.17). After adjustment for publication bias, T1ρ relaxation time of the LT remained non-significant (SMD = 0.17\[95% CI:-0.38;0.71\]; *p* = 0.54).

For meta-analyses assessing T2 relaxation time, heterogeneity was significant for all analyzed compartments (I^2^ = 77--87%; *p* \< 0.01) except for the TrF compartment (I^2^ = 31%; *p* = 0.19). Four studies consistently contributed to the heterogeneity of T2 relaxation SMD, including two studies fitting in the cartilage injury subgroup. Removal of these studies resulted in non-significant heterogeneity in the MF and P compartments (I^2^ = 19--23%; *p* \> 0.2); however, heterogeneity remained high after removal of outliers in the MT and LF compartments (I^2^ = 66--70%, *p* \> 0.01). After removal of outliers, T2 relaxation time remained significantly prolonged for those at risk for knee OA. For meta-analyses assessing T1ρ relaxation time, heterogeneity was significant for the MF and LT compartments (I^2^ = 44--87%; *p* \< 0.01), and non-significant for all other compartments (I^2^ = 0--28%; *p* = 0.15--0.94). The trim & fill method \[[@CR41]\] is limited in its ability to identify publication bias in heterogeneous datasets where no true bias exists \[[@CR95]\]. Thus there may be no significant publication bias for the heterogeneous SMD's of T1ρ in the MF and LT compartments.

Sensitivity analyses {#Sec16}
--------------------

We performed two sensitivity analyses. The first analysis excluded all but one study (6 articles excluded) using OAI data to ensure no subjects in the meta-analyses were used more than once. Effect sizes remained moderate and significant in all compartments (SMD = 0.38--0.73; *p* \< 0.02). The second analysis excluded all studies which used within-patient comparisons (healthy knee versus at-risk knee). Following exclusion of articles (6 articles for T2, 6 for T1ρ), effect sizes remained moderate-to-large for T2 (all compartments: SMD = 0.42--0.83; *p* \< 0.1), and remained moderate for some T1ρ compartments (MF, MT, LF: SMD = 0.27--0.37; *p* \< 0.02) and remained small and non-significant for others (LT, P, TrF: SMD = 0.13--0.14; *p* \> 0.29. Detailed results of sensitivity analyses can be found in Additional file [1](#MOESM1){ref-type="media"}: Appendix 3.

Subgroup analyses {#Sec17}
-----------------

We performed three subgroup analyses to determine respective effect sizes for patients with ACL injury, risk for patellofemoral OA, and articular cartilage lesions. Results of the subgroup analyses suggested that SMDs controls were small-to-moderate for the ACL-injury subgroup compared to controls (14 articles for T2: SMD = 0.13--0.56; *p* = 0.002--0.27. 14 articles for T1ρ: SMD = -0.11--0.30; *p* = 0.001--0.8). We obtained similar small-to-moderate effect sizes for the patellofemoral OA risk subgroup (8 articles for T2: SMD = 0.06--0.20; *p* = 0.004--0.78. 3 articles for T1ρ: SMD = -0.13--0.28; *p* = 0.06--0.89). These effect sizes were generally smaller compared to the remainder of the sample in the primary analysis. The articular cartilage injury subgroup demonstrated large effect sizes (4 articles for T2: SMD = 1.29--2.88; p = 0.001--0.38) which were larger in comparison to the remainder of the sample in the primary analysis. Detailed results of subgroups analyses can be found in Additional file [1](#MOESM1){ref-type="media"}: Appendix 4.

Discussion {#Sec18}
==========

The present pooled within-study effect sizes that combine data from 47 studies involving 3661 participants suggest T2 and T1ρ relaxation times distinguish between healthy participants and participants at risk for knee OA. The present results are consistent with the only other published systematic review we are aware of \[[@CR23]\], yet extends its findings by focusing on persons at-risk for but without radiographic knee OA, and by providing a thorough summary of the variable T2 and T1ρ collection, processing, and analysis methods. Strengths of the present study include adherence to well-established guidelines for conducting systematic reviews and meta-analyses \[[@CR35]\]. These include multiple reviewers reaching consensus at each step of the literature search, study selection and data extraction; assessment of study quality; assessment and adjustment for publication bias; and pre-planned meta-analyses including sensitivity analyses based on a priori hypotheses in the event of substantial heterogeneity. Limitations of the present meta-analyses may include pooling participants at risk, as there are likely several different phenotypes for the development of OA \[[@CR90]\]. Our subgroup analyses suggest that T2 and T1ρ values of articular cartilage are slightly different across participants with various risk factors, and future research should explore those differences further. A common methodological limitation in the studies included in this review is the lack of blinding and/or reporting of blinding procedures. Other limitations include those inherent to cross-sectional versus prospective designs that measure change in patient status over time.

Importantly, there was considerable variability between MRI methods, including scanners, coils, software, scanning protocols, pulse sequences, and post-processing, which can all influence T2 or T1ρ relaxation. For example, knee articular cartilage T2 relaxation time is inversely proportional to magnetic field strength \[[@CR96]\], and can differ significantly when using different brands of scanners of the same advertised field strength \[[@CR97]\]. In this review alone, four brands of scanners, and two magnet strengths were identified across studies (Table [1](#Tab1){ref-type="table"}). T2 relaxation time is significantly prolonged when using a phased-array knee coil compared to a quadrature transmit receive knee coil \[[@CR98]\]. Sixteen different knee coils were used in studies in this review (Table [1](#Tab1){ref-type="table"}), with a wide variety of phased-array and quadrature coils. Choice of pulse sequence can also significantly affect relaxation time, with a difference of as much as 10 ms observed across commonly used sequences \[[@CR99], [@CR100]\]. Knowledge of the context and collection methods is important when comparing compositional MRI values across the literature, as a 1.8 ms increase in T2 relaxation time is representative of a 1% increase in free water content when comparing within the same participant \[[@CR101], [@CR102]\]. Seventeen different pulse sequences were used to collect the data presented in this review (Table [1](#Tab1){ref-type="table"}). Pre-scan unloading protocol is an important consideration that varies across studies, as T2 relaxation time increases with unloading time due to water reuptake into the cartilage \[[@CR93]\]. Post-processing and segmentation can also affect T2 and T1ρ values, such as how the assessor defines the ROI, ROI variance between studies, number of slices included in the ROI \[[@CR103]\], proximity of borders to other tissues, and partial volume effects \[[@CR104]\]. Continued use of proposed standardized nomenclature and ROI definition will improve comparability of ROI's across studies and sites \[[@CR105]\]. Taken together, these findings identify substantial differences in methods across testing sites, suggest considerable caution should be adopted when making comparisons across studies, and highlight the limitation in the current state of T2 or T1ρ relaxation as imaging biomarkers.

These findings suggest future use of compositional MRI measures as potential biomarkers would benefit considerably from a greater understanding of the effects of different testing methods \[[@CR106]\] and greater standardization of data collection and analysis measures \[[@CR34]\]. The importance of greater standardization across testing sites is underscored by the variability in results of studies evaluating the test-retest reliability of compositional MRI measures, even when the exact same methods are used \[[@CR28]\]. For example, studies evaluating test-retest reliability using the same testing conditions report intra-class correlation coefficients (ICC) ranging from 0 to 0.98 \[[@CR107], [@CR108]\], and coefficients of variation (CV) ranging from 1.7 to 22.2 \[[@CR65], [@CR96]--[@CR98], [@CR106], [@CR109]--[@CR116]\]. Fewer studies evaluating test-retest reliability using similar methods but different scanner manufacturers suggest ICCs ranging from 0.2 to 0.93 \[[@CR107]\], and CVs ranging from 2.3 to 6.3 \[[@CR97], [@CR106]\]. Arguably, the most important consideration regarding improved reliability of compositional MRI as an imaging biomarker is comparability of values across scanners and centers. The present findings therefore support current international efforts from researchers and vendors to improve sequences, calibration, and standardization \[[@CR17]\], such as the Radiological Society of North America Quantitative Imaging Biomarker Alliance \[[@CR117]\], and multicenter studies such as the OAI \[[@CR118]\]. In addition to these efforts, another approach may be the use of calibration phantoms \[[@CR119]\] to develop correction functions to account for varying hardware and software used by different centers \[[@CR17]\].

By pooling within-study comparisons, the present primary analysis indicates that T2 and T1ρ relaxation times in articular cartilage are significantly prolonged in knees at risk for developing OA, especially in the more commonly affected compartments. T2 relaxation time was significantly prolonged in participants at risk for knee OA in all analyzed compartments with effect sizes ranging from small-to-moderate (SMD = 0.33--0.74; *p* \< 0.001), suggesting T2 is sensitive to early changes in collagen orientation and structural integrity \[[@CR120]\], as well as water content in these at-risk participants \[[@CR13], [@CR15], [@CR16]\]. These findings add support to the use of T2 relaxation time for early detection of OA, before substantial radiographic changes are evident, and support further efforts towards compositional MRI biomarker validation and qualification.

Interestingly, effect sizes for T1ρ relaxation time were small, and lower for each analyzed compartment in comparison to effect sizes for T2 relaxation time, (SMD = 0.04--0.40; *p* = 0.001--0.76), and only the MF and LF compartments demonstrated significantly prolonged T1ρ relaxation time compared to healthy controls (SMD = 0.35--0.40; *p* \< 0.001). However, there were fewer studies that included T1ρ as an outcome measure with generally smaller sample sizes. More research comparing T2 and T1ρ relaxation times for participants at various stages of knee OA is required.

In all knee compartments, there was significant heterogeneity associated with the overall pooled effect sizes for T2 relaxation time (Figs. [2](#Fig2){ref-type="fig"}, [3,](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}). Sensitivity analysis suggested that the high effect sizes of the cartilage injury subgroups are responsible for this heterogeneity (SMD = 1.29--2.88; p = 0.001--0.38), and after removal from the analyses, heterogeneity was no longer significant in the MF and P compartments (I^2^ = 19--23%; *p* \> 0.2) but remained moderate in the MT and LF compartments (I^2^ = 66--70, *p* \> 0.01). There were no articles assessing T1ρ relaxation time of participants with cartilage injury, which may explain the lack of heterogeneity in the T1ρ meta-analyses. The large effect sizes observed in these studies including patients with cartilage injury may be due to the different mechanopathology as a result of focal defects \[[@CR18]\] in comparison to other participants in this systematic review. Alternatively, we must acknowledge the substantial difference in age between this at-risk subgroup and controls. Publication bias was also significant in three compartments for T1ρ relaxation time, which may be due to the relative novelty of such measures in comparison to T2 relaxation time. There was no publication bias observed in any meta-analyses assessing T2 relaxation time.

Conclusions {#Sec19}
===========

Based on these results, T2 and T1ρ relaxometry of articular cartilage show substantial promise in their ability to identity pathological cartilage in participants at risk for knee OA. The present results are consistent with cross-sectional studies reporting known risk factors, such as increased age \[[@CR89]\], body mass \[[@CR42]\], and knee malalignment \[[@CR111]\], and their association with significantly prolonged articular cartilage T2 relaxation times. The present study also highlights the wide variety of methods currently used to collect, process, and analyze T2 and T1ρ mapping. Overall, the present results emphasize both the potential, as well as the need for greater standardization of methods across sites for T2 and T1ρ data collection and processing procedures to make greater gains toward potential biomarker validation.

Additional file
===============

 {#Sec20}

Additional file 1:Appendix 1 Search Strategy List of terms used to search the databases for eligible studies in the systematic review and meta-analyses. Appendix 2 Title of Data: Risk of Bias in Non-randomized Studies - of Interventions (ROBINS-I) Summary of the quality assessment for all studies using the ROBINS-I tool, grading studies on seven domains (confounding, participant selection bias, intervention bias, deviation from intervention, missing data, outcome measurement bias, outcome reporting bias) and their associated risk of bias (low, moderate, or severe). Appendix 3 Summary of Sensitivity Analyses Results of sensitivity analyses to account for potential bias of duplicate inclusions of participants as part of the Osteoarthritis Initiative, as well as potential for bias of studies using within-subject designs (healthy knee versus at-risk knee within the same participant). Appendix 4 Summary of Subgroup Analyses Results of subgroup analyses to investigate potential differences in effect sizes for groups with specific risk factors (anterior cruciate ligament injury, risk for patellofemoral osteoarthritis, and articular cartilage injuries. Appendix 5 Preferred Reporting of Items in Systematic Reviews and Meta-Analyses (PRISMA) Checklist PRISMA table identifying where in the text all required aspects of the checklist can be found in the manuscript. (DOCX 40 kb)

95% CI

:   95% confidence interval

ACL

:   Anterior cruciate ligament

CINAHL

:   Cumulative Index to Nursing & Allied Health Literature

CV

:   Coefficient of variation

dGEMRIC

:   Delayed gadolinium enhanced magnetic resonance imaging of cartilage

gagCEST

:   Glycosaminoglycan chemical exchange saturation transfer

ICC

:   Intra-class correlation coefficient

ICRS

:   International Cartilage Repair Society

KL

:   Kellgren & Lawrence

LF

:   Lateral femur

LT

:   Lateral tibia

MF

:   Medial femur

MRI

:   Magnetic resonance imaging

MT

:   Medial tibia

OA

:   Osteoarthritis

OAI

:   Osteoarthritis Initiative

P

:   Patella

PRISMA

:   Preferred Reporting Items for Systematic Reviews and Meta-Analyses

ROBINS-I

:   Risk of Bias in Non-randomized Studies - of Interventions

ROI

:   Region of interest

SD

:   Standard deviation

SMD

:   Standardized mean difference

TrF

:   Trochlea of femur
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